Companies / Vergent Bioscience
Vergent Bioscience
Minneapolis, United States
Vergent Bioscience is a clinical-stage biotechnology company that is helping surgeons realize the full potential of minimally invasive and robotic-assisted surgery by improving the visibility of tumors.
Vergent Bioscience, based in Minneapolis, United States, has 1 investor on file, among them Colle Capital. Its site was last checked 20 Nov 2026: site answers.
SEC Form D filings
6 filingsFiled by Vergent Bioscience, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Colle Capital
51 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (27%), AI & Machine Learning (23%), Enterprise Software (21%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Vergent Bioscience and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Colle Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/vergentbio.com/investors
# also
GET /v1/companies/vergentbio.com
GET /v1/companies/vergentbio.com/news